top of page

ENGINEERING HOPE FOR ADULTS AND CHILDREN WITH LIVER DISEASE

Our mission is to transform the treatment of liver disease

ReLiver: Morphocell's engineered tissue simply explained in its future potential to treat liver disease.

Video powered by Life Science Animation

Our Solution: ReLiver

®

Using advanced tissue engineering, we’re developing the world’s first effective treatments for the most dire liver diseases

UPDATES

Cell Therapy Product Development Expert Dr. Panos Chrysanthopoulos Joins Morphocell Technologies as Chief Development Officer

Morphocell Technologies to Present at 2023 Biotech Showcase

cover2_iPSC-derived hepatocyte-like cells_CK18-DAPI.png

Morphocell Technologies Announces a New Stem Cell Process that May Pave Way for Liver Cell Therapy and Drug Development

The US Patent Office has granted Morphocell Technologies a first patent for its Encapsulated Liver Tissue platform

Morphocell partners with CQDM and Takeda Pharmaceuticals to support the development of its ReLiver technology

Partnership Advances Large Animal Model Testing

bottom of page